We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiovascular Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00839579
Recruitment Status : Completed
First Posted : February 9, 2009
Last Update Posted : March 7, 2014
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:

Exercise training is proved to protect against premature cardiovascular mortality. Additionally there is evidence that relatively high exercise intensity may be an important factor for improving aerobic capacity and endothelial function in patients with post-infarction heart failure, metabolic syndrome, coronary artery disease, as well as in overweight and obese individuals.

The aim of this study is to investigate the amount of high-intensity exercise needed to improve aerobic capacity and endothelial function.


Condition or disease Intervention/treatment
Obesity Other: 1x4 min interval

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 26 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: How Little Pain for Cardiac Gain? A Pilot Study
Study Start Date : January 2009
Primary Completion Date : December 2009
Study Completion Date : June 2010

Arm Intervention/treatment
Experimental: 4x4min
4x4minutes interval group
Other: 1x4 min interval
Aerobic interval training
Experimental: 1x4min Other: 1x4 min interval
Aerobic interval training



Primary Outcome Measures :
  1. Maximal oxygen consumption and endothelial function [ Time Frame: baseline and 12 weeks followup ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI: 25-30
  • Males, 35-45 years
  • Healthy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00839579


Locations
Norway
Norwegian University of Science and Technology
Trondheim, Norway, 7489
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Study Chair: Arnt E Tjønna, PhD Norwegian University of Science and Technology
Principal Investigator: Ulrik Wisløff, PhD Norwegian University of Science and Technology

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00839579     History of Changes
Other Study ID Numbers: 1x4min interval
First Posted: February 9, 2009    Key Record Dates
Last Update Posted: March 7, 2014
Last Verified: March 2014

Keywords provided by Norwegian University of Science and Technology:
slightly overweight
males 35-45 years